Biocept Inc Receives Patent for its Primer-Switch Technology in Australia
Biocept Inc., (a San Diego-based commercial-stage cancer diagnostics company providing liquid biopsy tests for doctors and their patients with cancer) has quite recently won a new patent in Australia. The granted patent provides Intellectual Property (IP) Protection to Biocept’s Primer-Switch technology that is efficient and useful in performing ctDNA (circulating tumor DNA) analysis with the help […]
Read More